Accelerator Life Science Partners


Accelerator Life Science Partners is a venture capital firm focused on investing in and nurturing early-stage biotechnology companies. The firm is dedicated to advancing life sciences breakthroughs into impactful health solutions. With a strategic approach to biotech investing, Accelerator LSP partners with research institutions and corporate VCs to support emerging biotechnology research opportunities, particularly in New York City and Seattle.

Industries

N/A

Nr. of Employees

small (1-50)

Accelerator Life Science Partners


Portfolio

Acquired by Amgen for $721 million.

#Biotechnology

Acquired by Zymergen Inc.

#Biotechnology

Developing a new class of drugs targeting resistance to cancer therapy.

#Biotechnology

Focused on developing targeted neuroprotective therapies.

#Biotechnology

Supporting the development of Tezampanel in the treatment of seizure disorders.

#Biotechnology

Launched with $16M in Series A commitments in Singapore.

#Biotechnology

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.